Literature DB >> 25645909

Blunted suppression of acyl-ghrelin in response to fructose ingestion in obese adolescents: the role of insulin resistance.

Michelle Van Name1, Cosimo Giannini, Nicola Santoro, Ania M Jastreboff, Jessica Kubat, Fangyong Li, Romy Kursawe, Mary Savoye, Elvira Duran, James Dziura, Rajita Sinha, Robert S Sherwin, Gary Cline, Sonia Caprio.   

Abstract

OBJECTIVE: Fructose consumption has risen alongside obesity and diabetes. Gut hormones involved in hunger and satiety (ghrelin and PYY) may respond differently to fructose compared with glucose ingestion. This study evaluated the effects of glucose and fructose ingestion on ghrelin and PYY in lean and obese adolescents with differing insulin sensitivity.
METHODS: Adolescents were divided into lean (n = 14), obese insulin sensitive (n = 12) (OIS), and obese insulin resistant (n = 15) (OIR). In a double-blind, cross-over design, subjects drank 75 g of glucose or fructose in random order, serum was obtained every 10 minutes for 60 minutes.
RESULTS: Baseline acyl-ghrelin was highest in lean and lowest in OIR (P = 0.02). After glucose ingestion, acyl-ghrelin decreased similarly in lean and OIS but was lower in OIR (vs. lean, P = 0.03). Suppression differences were more pronounced after fructose (lean vs. OIS, P = 0.008, lean vs. OIR, P < 0.001). OIS became significantly hungrier after fructose (P = 0.015). PYY was not significantly different at baseline, varied minimally after glucose, and rose after fructose.
CONCLUSIONS: Compared with lean, OIS adolescents have impaired acyl-ghrelin responses to fructose but not glucose, whereas OIR adolescents have blunted responses to both. Diminished suppression of acyl-ghrelin in childhood obesity, particularly if accompanied by insulin resistance, may promote hunger and overeating.
© 2015 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645909      PMCID: PMC4548801          DOI: 10.1002/oby.21019

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  40 in total

1.  Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.

Authors:  Karen L Teff; Sharon S Elliott; Matthias Tschöp; Timothy J Kieffer; Daniel Rader; Mark Heiman; Raymond R Townsend; Nancy L Keim; David D'Alessio; Peter J Havel
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

Review 2.  Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions.

Authors:  Garth H Ballantyne
Journal:  Obes Surg       Date:  2006-05       Impact factor: 4.129

3.  The nutritional control of ghrelin secretion in humans: the effects of enteral vs. parenteral nutrition.

Authors:  Flavia Prodam; Elisa Me; Fabrizio Riganti; Elena Gramaglia; Simonetta Bellone; Roberto Baldelli; Anna Rapa; Aart Jan van der Lely; Gianni Bona; Ezio Ghigo; Fabio Broglio
Journal:  Eur J Nutr       Date:  2006-09-07       Impact factor: 5.614

4.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

5.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

6.  Ghrelin increases food intake in obese as well as lean subjects.

Authors:  M R Druce; A M Wren; A J Park; J E Milton; M Patterson; G Frost; M A Ghatei; C Small; S R Bloom
Journal:  Int J Obes (Lond)       Date:  2005-09       Impact factor: 5.095

7.  Fasting and postprandial relationships among plasma leptin, ghrelin, and insulin in prepubertal obese children.

Authors:  M Gil-Campos; C M Aguilera; M C Ramirez-Tortosa; R Cañete; A Gil
Journal:  Clin Nutr       Date:  2009-07-19       Impact factor: 7.324

8.  Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages.

Authors:  J Bowen; M Noakes; P M Clifton
Journal:  Int J Obes (Lond)       Date:  2007-06-26       Impact factor: 5.095

9.  The change in ghrelin and obestatin levels in obese children after weight reduction.

Authors:  Chao Chun Zou; Li Liang; Chun Lin Wang; Jun Fen Fu; Zheng Yan Zhao
Journal:  Acta Paediatr       Date:  2008-08-14       Impact factor: 2.299

10.  Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26).

Authors:  Alison N Jeffery; Brad S Metcalf; Joanne Hosking; Adam J Streeter; Linda D Voss; Terence J Wilkin
Journal:  Diabetes Care       Date:  2012-01-25       Impact factor: 19.112

View more
  14 in total

1.  Fructose Consumption Contributes to Hyperinsulinemia in Adolescents With Obesity Through a GLP-1-Mediated Mechanism.

Authors:  Alfonso Galderisi; Cosimo Giannini; Michelle Van Name; Sonia Caprio
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

2.  Jejunal administration of glucose enhances acyl ghrelin suppression in obese humans.

Authors:  Robyn A Tamboli; Reem M Sidani; Anna E Garcia; Joseph Antoun; James M Isbell; Vance L Albaugh; Naji N Abumrad
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-07       Impact factor: 4.310

3.  Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.

Authors:  William S Denney; Gabriele E Sonnenberg; Santos Carvajal-Gonzalez; Theresa Tuthill; V Margaret Jackson
Journal:  Br J Clin Pharmacol       Date:  2016-10-29       Impact factor: 4.335

4.  Food craving, cortisol and ghrelin responses in modeling highly palatable snack intake in the laboratory.

Authors:  Rajita Sinha; Peihua Gu; Rachel Hart; J B Guarnaccia
Journal:  Physiol Behav       Date:  2019-05-27

5.  Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.

Authors:  J Kong; J Chuddy; I A Stock; P M Loria; S V Straub; C Vage; K O Cameron; S K Bhattacharya; K Lapham; K F McClure; Y Zhang; V M Jackson
Journal:  Br J Pharmacol       Date:  2016-03-17       Impact factor: 8.739

6.  Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis.

Authors:  Maria T Vamvini; Ole-Petter Hamnvik; Ayse Sahin-Efe; Anna Gavrieli; Fadime Dincer; Olivia M Farr; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2016-03-10       Impact factor: 5.958

7.  High fructose-containing drinking water-induced steatohepatitis in rats is prevented by the nicotinamide-mediated modulation of redox homeostasis and NADPH-producing enzymes.

Authors:  S S Loza-Medrano; L A Baiza-Gutman; L Manuel-Apolinar; R García-Macedo; L Damasio-Santana; O A Martínez-Mar; M C Sánchez-Becerra; M Cruz-López; M A Ibáñez-Hernández; M Díaz-Flores
Journal:  Mol Biol Rep       Date:  2019-10-24       Impact factor: 2.316

8.  Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome.

Authors:  Robert H Lustig; Kathleen Mulligan; Susan M Noworolski; Viva W Tai; Michael J Wen; Ayca Erkin-Cakmak; Alejandro Gugliucci; Jean-Marc Schwarz
Journal:  Obesity (Silver Spring)       Date:  2015-10-26       Impact factor: 5.002

9.  Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of Obesity, Insulin Resistance, and Sex.

Authors:  Alexandra G Yunker; Shan Luo; Sabrina Jones; Hilary M Dorton; Jasmin M Alves; Brendan Angelo; Alexis DeFendis; Trevor A Pickering; John R Monterosso; Kathleen A Page
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

Review 10.  Health effects of fructose and fructose-containing caloric sweeteners: where do we stand 10 years after the initial whistle blowings?

Authors:  Luc Tappy; Kim-Anne Lê
Journal:  Curr Diab Rep       Date:  2015-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.